Koliber Biosciences is a computational biology company that specializes in building machine learning models for peptide discovery and optimization. Koliber has developed a patent-pending deep learning based platform that enables training of target specific models of peptide activity to improve peptide potency and selectivity. Moreover, Koliber has several pre-trained peptide property models to predict peptide solubility, serum stability and permeability. In addition, we have wet lab capabilities to perform hit discovery and lead optimization for novel targets. The Koliber platform has been extensively validated in several application areas including immunology, metabolic disease and antimicrobials. The company is based in San Diego, CA with a world-class team of advisors with expertise in peptide drug discovery, data mining and machine learning.
Company Details
- Employees
- 4
- Founded
- 2014
- Address
- San Diego, San Diego,ca,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.koliberbio.com
- Keywords
- Statistics, Data Science, Machine Learning, Biotechnology, Microbiome, Probiotics, Synthetic Biology, Drug Discovery, Artificial Intelligence, Peptides, Proteins.
- HQ
- San Diego, CA
Koliber Biosciences Questions
Koliber Biosciences's website is http://www.koliberbio.com
Koliber Biosciences's LinkedIn profile is https://www.linkedin.com/company/koliber-biosciences
Koliber Biosciences has
4 employees.
View email and phone details for 4
employees at Koliber Biosciences.
Koliber Biosciences's industry is
Biotechnology Research
Koliber Biosciences's top competitors are
Arzeda,
Koliber Engineering,
The Peptide Therapeutics Foundation,
Qpex Biopharma, Inc.,
Navy Marine Corp Relief Society,
Ottomait,
Blue Gum Advisors Llc,
Space Peptides Pharmaceutical Co., Ltd.,
Natera,
Revolution Medicines.
Koliber Biosciences's categories are Biotechnology Research
Koliber Biosciences's founding year is 2014
